Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

黃惠君 (Hui-Chun Huang)

[Profile]

  • Education
    • M.D. Yang-Ming Medical University,
  • Career and Experience
    Current Positions:
    • - Now, Attending Physician, Division of Gastroenterology and Hepatology, Department of Medicine , Taipei Veterans General Hospital, Taiwan,,
    • - Now, Attending Physician, Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital,
    Experiences:
    • - , Chief, Division of General Medicine, Taipei Veterans General Hospital,
    • - , Research fellow, Liver center, Yale University School of Medicine, Connecticut, U.S.A.,
    • - , Resident and Chief resident, Department of Medicine, Taipei Veterans General Hospital,
    • - , Professor Faculty of Medicine, National Yang-Ming Chiao-Tung University,
    • - , Associate professor Faculty of Medicine, National Yang-Ming University,
  • Medical Expertise
    1. Mechanism and treatment strategy of liver cirrhosis and portal hypertension, alcoholism
  • License
    Board-certified Physician, Diploma of Department of Health, Executive Yuan, Taiwan Board-certified Gastroenterologist and Instructor, Diploma of The Gastroenterological Society of Taiwan Board-certified Digestive Endoscopist and Instructor, Diploma of The Digestive Endoscopy Society of Taiwan

[Publications]

1. Hsu SJ, Huang HC, Pun CK, Chang CC, Chuang CL, Huang YH, Hou MC, Lee FY. Sodium-glucose cotransporter-2 inhibition exacerbates hepatic encephalopathy in biliary cirrhotic rats. J Pharmacol Exp Ther 2022:JPET-AR-2022-001289.

2. Huang HC, Ho HL, Chang CC, Chuang CL, Pun CK, Lee FY, Huang YH, Hou MC, Hsu SJ. Matrix metalloproteinase-9 inhibition or deletion attenuates portal hypertension in rodents. J Cell Mol Med 2021;25:10073-10087.

3. Huang HC, Tsai MH, Chang CC, Pun CK, Huang YH, Hou MC, Lee FY, Hsu SJ. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats. Clin Sci (Lond) 2021;135:2709-2728.

4. Hsin IF, Huang HC, Chang CC, Hsu SJ, Lee FY, Huo TI, Chuang CL, Hou MC, Lee SD. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes. Clin Sci (Lond) 2018;132:2391-2405.

5. Hsu SJ, Tsai MH, Chang CC, Hsieh YH, Huang HC, Lee FY, Chuang CL, Hou MC, Lee SD. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution. Clin Sci (Lond) 2018;132:669-683.

回到最上